152 related articles for article (PubMed ID: 1581211)
21. Elevated serum-soluble interleukin-2 receptor (Tac antigen) levels in chronic myelogenous leukemia patients with blastic crisis.
Motoi T; Uchiyama T; Hori T; Itoh K; Uchino H; Ueda R
Blood; 1989 Aug; 74(3):1052-7. PubMed ID: 2787681
[TBL] [Abstract][Full Text] [Related]
22. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
23. Requirements for the induction of the interleukin-2 receptor complex in a human pre-T-cell line.
Salvati PD; Peroni SE; Ranford PR; Kees UR
Immunology; 1993 Mar; 78(3):449-54. PubMed ID: 8478026
[TBL] [Abstract][Full Text] [Related]
24. Expression of the leucocyte common antigen (LCA, CD45) isoforms RA and RO in acute haematological malignancies: possible relevance in the definition of new overlap points between normal and leukaemic haemopoiesis.
Schiavone EM; Lo Pardo C; Di Noto R; Manzo C; Ferrara F; Vacca C; Del Vecchio L
Br J Haematol; 1995 Dec; 91(4):899-906. PubMed ID: 8547136
[TBL] [Abstract][Full Text] [Related]
25. Targeting human IL-2 receptors for diagnosis and therapy.
Nelson DL; Kurman CC
Proc Soc Exp Biol Med; 1994 Jul; 206(3):309-11. PubMed ID: 8016170
[TBL] [Abstract][Full Text] [Related]
26. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells.
Bruserud O
Cancer Immunol Immunother; 1998 Jun; 46(4):221-8. PubMed ID: 9671145
[TBL] [Abstract][Full Text] [Related]
27. Independent expression of p55 and p75 interleukin-2 receptors (IL-2R) during intravenous or subcutaneous administration of recombinant interleukin-2 (rIL-2) by T-lymphocytes and natural killer cells.
Zambello R; Trentin L; Cerutti A; Enthammer C; Milani A; Franceschi T; Messina C; Cetto GL; Agostini C; Semenzato G
Cancer; 1994 Nov; 74(9):2562-9. PubMed ID: 7522954
[TBL] [Abstract][Full Text] [Related]
28. An HTLV-I carrier who developed CD4+ T-CLL expressed the IL-2 receptor beta chain alone without expressing the alpha chain.
Mori N; Murakami S; Oda S; Eto S
Br J Haematol; 1993 Sep; 85(1):185-7. PubMed ID: 7902734
[TBL] [Abstract][Full Text] [Related]
29. Functional interleukin-2 receptor on a Tac negative human leukaemia T-cell line.
Kees UR; Ford J; Peroni SE; Ranford PR
Leuk Res; 1993 Jan; 17(1):51-9. PubMed ID: 8429680
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 5 up-regulates high-affinity interleukin 2 receptor expression by human resting peripheral T cells: a comparison with the effect of interleukin 4 on B cells.
Hara M; Kitani A; Harigai M; Hirose T; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Kawagoe M
Cytokine; 1991 Nov; 3(6):584-92. PubMed ID: 1790306
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the ovine interleukin-2 receptor-alpha chain: differential induction on precultured alpha beta and gamma delta T cells.
Verhagen AM; Brandon MR; Nash AD
Immunology; 1993 Jul; 79(3):471-8. PubMed ID: 8406574
[TBL] [Abstract][Full Text] [Related]
32. Leukaemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with myelodysplasia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schmid C; Schweiger C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):75-85. PubMed ID: 16091127
[TBL] [Abstract][Full Text] [Related]
33. Leukemia-derived dendritic cells can be generated from blood or bone marrow cells from patients with acute myeloid leukaemia: a methodological approach under serum-free culture conditions.
Kufner S; Zitzelsberger H; Kroell T; Pelka-Fleischer R; Salem A; de Valle F; Schweiger C; Nuessler V; Schmid C; Kolb HJ; Schmetzer HM
Scand J Immunol; 2005 Jul; 62(1):86-98. PubMed ID: 16091128
[TBL] [Abstract][Full Text] [Related]
34. Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.
Richardson JH; Sodroski JG; Waldmann TA; Marasco WA
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3137-41. PubMed ID: 7724529
[TBL] [Abstract][Full Text] [Related]
35. Generation of monoclonal antibodies to the rabbit interleukin-2 receptor alpha chain (CD25) and its distribution in HTLV-1-transformed rabbit T cells.
Kotani M; Yamamura Y; Tsudo M; Tamatani T; Kitamura F; Miyasaka M
Jpn J Cancer Res; 1993 Jul; 84(7):770-5. PubMed ID: 8370651
[TBL] [Abstract][Full Text] [Related]
36. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL
Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783
[TBL] [Abstract][Full Text] [Related]
37. [The responses of leukemia cells to interleukin-2 in vitro].
Yang Y
Hua Xi Yi Ke Da Xue Xue Bao; 1997 Jun; 28(2):188-92. PubMed ID: 10683932
[TBL] [Abstract][Full Text] [Related]
38. Analysis of the TNF receptors on human leukaemia cells by affinity cross-linking.
Elbaz O; Mahmoud LA; Touw IP; Löwenberg B
Br J Haematol; 1992 Aug; 81(4):530-2. PubMed ID: 1327064
[TBL] [Abstract][Full Text] [Related]
39. Potential to target dysregulated interleukin-2 receptor expression in canine lymphoid and hematopoietic malignancies as a model for human cancer.
Dickerson EB; Fosmire S; Padilla ML; Modiano JF; Helfand SC
J Immunother; 2002; 25(1):36-45. PubMed ID: 11924909
[TBL] [Abstract][Full Text] [Related]
40. Role of alpha chain-IL-2 complex in the formation of the ternary complex of IL-2 and high-affinity IL-2 receptor.
Kamio M; Uchiyama T; Arima N; Itoh K; Ishikawa T; Hori T; Uchino H
Int Immunol; 1990; 2(6):521-30. PubMed ID: 2085490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
